Abstract
Leukotriene B4 (LTB4) is a proinflammatory product of arachidonic acid metabolism that has been implicated as a mediator in a number of inflammatory diseases. When injected intradermally into the cavine, LTB4 elicits a dose-dependent immigration (chemotaxis) of neutrophils (PMNs) into the injection sites as assessed by the presence of a neutrophil marker enzyme myeloperoxidase. SC-41930 {7-[3-(4-acetyl-3-methoxy-2-propylphenoxy)propoxy]-3,4-dihydro-8-propyl-2H-l-benzopyran-2-carboxylic acid, a potent LTB4 receptor antagonist inhibited the chemotactic actions of LTB4 when coadministered into the dermal site and when given intravenously or orally with ED50 values of 200 ng, 0.5 mg/kg, and 0.6 mg/ kg respectively. This compound may well have application in disease states, such as inflammatory bowel disease and psoriasis, where LTB4 is implicated as a proinflammatory mediator.
Similar content being viewed by others
References
Plamblad, J., C. Malmsten, A. Uden, O. Radmark, L. Engstrot, andB. Samuelson. 1981. Leukotriene B4 is a potent and stereospecific stimulator of neutrophil chemotaxis and adherence.Blood 58:658–661.
Redl, H., P. Flynn, H. Lamche, A. Schiesser, G. Schlag, andD. Hammerschmidt. 1983. Aggregation, chemotaxis and chemiluminesence of canine granulocytes.Inflammation 7:67–79.
Ford-Hutchison, A., M. Bray, M. Doig, M. Shipley, andM. Smith. 1980. Leukotriene B4, a potent chemokinetic and aggregating substance released from polymorphonuclear leukoctyes.Nature 286:264–265.
Hoover, R., M. Karnovsky, K. Austin, E. Corey, andR. Lewis. 1984. Leukotriene B4 action on endothelium mediates augmented neutrophil/endothelial adhesion.Proc. Natl. Acad. Sci. U.S.A. 81:2191.
Czarnetzki, B., andR. Mertensmeir. 1985. In vitro and in vivo chemotaxis of guinea pig leukocytes toward leukotriene B4 and itsω-oxidation products.Prostaglandins 30:5–11.
Colditz, I., andH. Movat. 1984. Kinetics of neutrophil accumulation in accute inflammatory lesions induced by chemotaxis and chemotaxinigens.J. Immunol. 133:2169–2173.
Bhattacherjee, P., B. Hammond, J. Salmon, R. Stepney, andK. Eakins. 1981. Chemotactic response to some arachidonic acid lipoxygenase products in the rabbit eye.Eur. J. Pharmacol. 73:21–28.
Camp, R., A. Coutts, M. Greaves, A. Kay, andM. Walport. 1983. Responses of human skin to intradermal injection of leukotrienes C4, D4 and B4.Br. J. Pharmacol. 8:497–502.
Soter, N., R. Lewis, E. Corey, andK. F. Austin. 1983. Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4 and LTB4) in human skin.J. Invest. Dermatol. 80:115–119.
Keith, R., W. Smith, B. Tsai, S. Levin, andG. Butchko. 1985. Myeloperoxidase activity in experimentally induced colitis.Fed. Proc. 44:1545.
Krawisz, J., P. Sharon, andW. Stenson. 1984. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity.Gastroenterology 87:1344–1350.
Bradley, P., D. Priebat, R. Christensen, andG. Rothstein. 1982. Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker.J. Invest. Dermatol. 78:206–209.
Fretland, D., S. Levin, B. Tsai, S. Djurić, D. Widomski, J. Zemaitis, R. Shone, andR. Bauer. 1989. The effect of a leukotriene-B4 receptor antagonist, SC-41930, on acetic acidinduced colonie inflammation.Agents Actions 27:225–227.
Smith, W., B., Cohen, S. Levin, andG. Butchko. 1986. In vivo chemotaxis to leukotriene-B4 detected by meyloperoxidase activity.Fed. Proc. 45:63.
Sharon, P., andW. Stenson. 1984. Enhanced synthesis of leukotriene-B4 by colonie mucosa in inflammatory bowel disease.Gastroenterology 86:453–460.
Ziboh, V., T. Casebolt, C. Marcelo, andJ. Voorhees. 1984. Biosynthesis of lipoxygenase products by enzyme preparations from normal and psoriatic skin.J. Invest. Dermatol. 83:426–430.
Brain, S., R. Camp, P. Dowd, A. Kobza-Black, andM. Greaves. 1984. The release of leukotriene-B4-like material in biologically active amounts from the lesional skin of patients with psoriasis.J. Invest. Dermatol. 83:70–73.
Lucchesi, B., andK. Mullane. 1986. Leukocytes and ischemia-induced myocardial injury.Annu. Rev. Pharmacol. Toxicol. 26:201–224.
Mullane, K. 1988. Eicosanoids in myocardial ischemia/reperfusions injury.Adv. Inflammation Res. 12:191–214.
Aked, D., andS. Foster, 1987. Leukotriene B4 and prostaglandin E2 mediate the inflammatory response of rabbit skin to intradermal arachidonic acid.Br. J. Pharmacol. 92:545–552.
McMillan, R., andS. Foster, 1988. Leukotriene B4 and inflammatory disease.Agents Actions 24:114–119.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fretland, D.J., Widomski, D.L., Zemaitis, J.M. et al. Effect of a leukotriene B4 receptor antagonist on leukotriene B4-induced neutrophil chemotaxis in cavine dermis. Inflammation 13, 601–605 (1989). https://doi.org/10.1007/BF00916766
Issue Date:
DOI: https://doi.org/10.1007/BF00916766